Endoscopic findings in a cohort of newly diagnosed gastroesophageal reflux disease patients registered in a UK primary care database

Diseases of the Esophagus

Volumn 20, Issue 6, 2007, Pages 504-509

  Ruigomez A ^a   Rodríguez, L A García ^a   Wallander, M A ^b,c   Johansson, S ^b,d   Dent, J ^e  

^a Centro Español de Investigación Farmacoepidemiológica ^*  (Spain)

^b ASTRAZENECA R AND D   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Barrett's esophagus; Epidemiology; Esophageal stenosis; Gastroesophageal reflux; Peptic esophagitis; Primary health care

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; BARRETT ESOPHAGUS; CHILD; ESOPHAGUS CANCER; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 35449001069     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00745.x     Document Type: Article

References (26)

1. Dent J, El-Serag H B, Wallander M A, Johansson S. Epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut 2005; 54: 710-17.
2. Ronkainen J, Aro P, Storskrubb T et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol 2005; 40: 275-85.
3. Zagari R M, Pozzato P, Damian S et al. Relationship between gastroesophageal reflux symptoms and esophagitis in the general population: Results from the Loiano-Monghidoro study. Gastroenterology 2006; 130: T1018.
4. Lagergren J. Adenocarcinoma of oesophagus: What exactly is the size of the problem and who is at risk? Gut 2005; 54 (Suppl 1): I1-5.
5. El-Serag H B. Temporal trends in new and recurrent esophageal strictures in the Department of Veterans Affairs. Am J Gastroenterol 2006; 101: 1727-33.
6. Ruigomez A, Garcia Rodriguez L A, Wallander M A, Johansson S, Graffner H, Dent J. Natural history of gastroesophageal reflux disease diagnosed in UK general practice. Aliment Pharmacol Ther 2004; 20: 751-60.
7. Jick H, Jick S S, Derby L E. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991; 302: 766-8.
8. Hollowell J (ed.). General Practice Research Database: Scope and Quality of Data. London: Office for Population Censuses and Surveys, 1994
9. Jick S S, Kaye J A, Vasilakis-Scaramozza C et al. Validity of the general practice research database. Pharmacotherapy 2003; 23: 686-9.
10. Garcia Rodriguez L A, Ruigomez A, Wallander M A, Johansson S, Stalhammar N O. Health resource utilization and drug treatment pattern in a cohort of patients with a first episode of gastroesophageal reflux disease. Pharmacoepidemiol Drug Saf 1999; 8: 493-500.
11. Johansson S, Wallander M A, Ruigomez A, Garcia Rodriguez L A. Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs? Aliment Pharmacol Ther 2003; 18: 973-8.
12. Eisendrath P, Tack J, Deviere J. Diagnosis of gastroesophageal reflux disease in general practice: A Belgian national survey. Endoscopy 2002; 34: 998-1003.
13. Nandurkar S, Locke G R 3rd, Murray J A et al. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol 2005; 100: 1459-65.
14. Jones R H, Hungin A P, Phillips J, Mills J G. Gastro-oesophageal reflux disease in primary care in Europe: Clinical presentation and endoscopic findings. Eur J General Pract 1995; 1: 149-54.
15. Thomson A B, Barkun A N, Armstrong D et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment -Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003; 17: 1481-91.
16. Kulig M, Nocon M, Vieth M et al. Risk factors of gastroesophageal reflux disease: Methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol 2004; 57: 580-9.
17. Wallace M B, Durkalski V L, Vaughan J et al. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: A multicentre database study. Gut 2001; 49: 29-34.
18. Bytzer P, Pless T. Bias introduced by patient history and intraobserver consistency for endoscopic assessment. A 'blinded' study of 129 endoscopists. Endoscopy 2004; 36: A53.
19. Voutilainen M, Sipponen P, Mecklin J P, Juhola M, Farkkila M. Gastroesophageal reflux disease: Prevalence, clinical, endoscopic and histopathological findings in 1128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000; 61: 6-13.
20. Winters C Jr, Spurling T J, Chobanian S J et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118-24.
21. Mann N S, Tsai M F, Nair P K. Barrett's esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol 1989; 84: 1494-6.
22. Caygill C P, Reed P I, Johnston B J, Hill M J, Ali M H, Levi S. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis. Eur J Gastroenterol Hepatol 1999; 11: 1355-8.
23. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
24. El-Serag H B, Johanson J F. Risk factors for the severity of erosive esophagitis in Helicobacter pylori -negative patients with gastroesophageal reflux disease. Scand J Gastroenterol 2002; 37: 899-904.
25. van Pinxteren B, Numans M E, Bonis P A, Lau J. Short-term treatment with proton pump inhibitors, H 2 -receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2004; 3: CD002095.
26. Donnellan C, Sharma N, Preston C, Moayyedi P. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2005; 4: CD003245.